Immunomodulation by adoptive regulatory T‐cell transfer improves Coxsackievirus B3‐induced myocarditis
Open Access
- 4 June 2018
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 32 (11) , 6066-6078
Abstract
Regulatory T (T reg ) cells offer new therapeutic options for controlling undesired systemic and local immune responses. The aim of the current study was to determine the impact of therapeutic T reg administration on systemic and cardiac inflammation and remodeling in coxsackievirus B3 (CVB3) ‐induced myocarditis. Therefore, syngeneic T reg cells were applied intravenously in CVB3‐infected mice 3 d after infection. Compared with CVB3 + PBS mice, CVB3 + T reg mice exhibited lower left ventricle (LV) chemokine expression, accompanied by reduced cardiac presence of proinflammatory Ly6C high CCR2 high Cx3Cr1 low monocytes and higher retention of proin flammatory Ly6C mid CCR2 high Cx3Cr1 low monocytes in the spleen. In addition, splenic myelopoiesis was reduced in CVB3 + Treg compared with CVB3 + PBS mice. Coculture of Treg cells with splenocytes isolated from mice 3 d post‐ CVB3 infection further demonstrated the ability of T reg cells to modulate monocyte differentiation in favor of the anti‐inflammatory Ly6C low CCR2 low Cx3Cr1 high subset. T reg ‐mediated immunomodulation was paralleled by lower collagen 1 protein expression and decreased levels of soluble and insoluble collagen in LV of CVB3 + T reg compared with CVB3 + PBS mice. In agreement with these findings, LV systolic and diastolic function was improved in CVB3 + T reg mice compared with CVB3 + PBS mice. In summary, adoptive T reg transfer in the inflammatory phase of viral‐induced myocarditis protects the heart against inflammatory damage and fibrosis via modulation of monocyte subsets.—Pappritz, K., Savvatis, K., Miteva, K., Kerim, B., Dong, F., Fechner, H., Müller, I., Brandt, C., Lopez, B., González, A., Ravassa, S., Klingel, K., Diez, J., Reinke, P., Volk, H.‐D., Van Linthout, S., Tschöpe, C. Immunomod ulation by adoptive regulatory T‐cell transfer improves Coxsackievirus B3‐induced myocarditis. FASEB J . 32, 6066–6078 (2018). www.fasebj.orgKeywords
This publication has 45 references indexed in Scilit:
- Adoptive Transfer of Regulatory T Cells Protects against Coxsackievirus B3-Induced Cardiac FibrosisPLOS ONE, 2013
- Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCsJournal of Clinical Investigation, 2012
- Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental MyocarditisPLOS ONE, 2012
- Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesisJournal of Experimental Medicine, 2012
- Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced MyocarditisPLOS ONE, 2011
- Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditisEuropean Heart Journal, 2010
- FoxP3+ Regulatory T Cells Restrain Splenic Extramedullary Myelopoiesis via Suppression of Hemopoietic Cytokine-Producing T CellsThe Journal of Immunology, 2009
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory SitesScience, 2009
- How regulatory T cells workNature Reviews Immunology, 2008
- CD4+CD25+Foxp3+regulatory T cells induce alternative activation of human monocytes/macrophagesProceedings of the National Academy of Sciences, 2007